Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract : Messenger RNA (mRNA) vaccine development for preventive and therapeutic applications has evolved rapidly over the last decade. The mRVNA vaccine has proven therapeutic efficacy in various applications, including infectious disease, immunotherapy, genetic disorders, regenerative medicine, and cancer. Many mRNA vaccines have made it to clinical trials, and a couple have obtained FDA approval.
Two potential viologen-based molecular lasso precursors—both composed of a 4,4'-bipyridinium (BIPY ) unit as part of a rope appended to a cyclobis(paraquat-p-phenylene) (CBPQT ) loop—that have been designed to mimic the threading / unthreading motion of lasso peptides, have been synthesised and characterised.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
